JP2022532187A5 - - Google Patents
Info
- Publication number
- JP2022532187A5 JP2022532187A5 JP2021566582A JP2021566582A JP2022532187A5 JP 2022532187 A5 JP2022532187 A5 JP 2022532187A5 JP 2021566582 A JP2021566582 A JP 2021566582A JP 2021566582 A JP2021566582 A JP 2021566582A JP 2022532187 A5 JP2022532187 A5 JP 2022532187A5
- Authority
- JP
- Japan
- Prior art keywords
- cys
- thr
- dota
- pah
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2019/061882 WO2020224780A1 (en) | 2019-05-08 | 2019-05-08 | Para-aminohippuric acid (pah) as a renal protective substance |
| EPPCT/EP2019/061882 | 2019-05-08 | ||
| PCT/EP2020/062950 WO2020225447A1 (en) | 2019-05-08 | 2020-05-08 | Para-aminohippuric acid (pah) as a renal protective substance |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022532187A JP2022532187A (ja) | 2022-07-13 |
| JP2022532187A5 true JP2022532187A5 (https=) | 2023-05-23 |
| JP7436512B2 JP7436512B2 (ja) | 2024-02-21 |
Family
ID=66484050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021566582A Active JP7436512B2 (ja) | 2019-05-08 | 2020-05-08 | 腎保護物質としてのパラアミノ馬尿酸（ｐａｈ） |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220304964A1 (https=) |
| EP (2) | EP4218749A1 (https=) |
| JP (1) | JP7436512B2 (https=) |
| KR (1) | KR102934560B1 (https=) |
| CN (1) | CN114126654B (https=) |
| AU (1) | AU2020268836B2 (https=) |
| BR (1) | BR112021022200A2 (https=) |
| CA (1) | CA3135331A1 (https=) |
| ES (1) | ES2938721T3 (https=) |
| WO (2) | WO2020224780A1 (https=) |
| ZA (1) | ZA202107431B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022096103A1 (en) * | 2020-11-05 | 2022-05-12 | ITM Isotopen Technologien München AG | Combination of para-aminohippuric acid (pah) and radiolabeled complexes for treating cancer |
| US11541134B1 (en) | 2021-08-02 | 2023-01-03 | Rayzebio, Inc. | Stabilized compositions of radionuclides and uses thereof |
| AU2021466145B2 (en) * | 2021-09-30 | 2026-03-26 | Paul Scherrer Institut | [161Tb]-BASED RADIOPEPTIDES |
| EP4603087A1 (en) * | 2022-11-21 | 2025-08-20 | Kyowa Hakko Bio Co., Ltd. | Prophylactic or therapeutic agent for acute kidney injury induced by anticancer agent |
| WO2025029946A1 (en) | 2023-07-31 | 2025-02-06 | Curium Us Llc | [177lu] lutetium-psma i&t composition and dosimetry, kit, method of making, and method of using thereof |
| WO2026027771A1 (en) | 2024-08-02 | 2026-02-05 | Trimt Gmbh | Alpha v beta 6-integrin binding cyclopeptides with non-natural amino acids, and conjugates thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT373177B (de) | 1982-05-12 | 1983-12-27 | Ver Edelstahlwerke Ag | Einrichtung zur durchfuehrung von umschmelzverfahren mit selbstverzehrenden elektroden |
| AU6275800A (en) | 1999-07-16 | 2001-02-05 | Mallinckrodt, Inc. | Inhibition of renal uptake of molecules that are potentially damaging for the kidney |
| JP4840401B2 (ja) * | 2003-10-15 | 2011-12-21 | ソニー株式会社 | 固体撮像装置、画素信号処理方法 |
| JP2006199688A (ja) * | 2004-12-20 | 2006-08-03 | Santen Pharmaceut Co Ltd | 角結膜障害治療剤 |
| EP1862172A1 (en) * | 2006-05-31 | 2007-12-05 | BioSynthema Inc. | Combination of amino acid solution and a gelatin for inhibiting renal uptake |
| CN101472593A (zh) * | 2006-06-19 | 2009-07-01 | 索尔瓦药物有限公司 | 腺苷a1拮抗剂在放射造影介质诱发的肾病中的用途 |
| US9061077B2 (en) * | 2008-05-05 | 2015-06-23 | Emory University | Methods of determining renal function using technetium-99m tricarbonyl-nitrilotriacetic acid |
| PL2970345T3 (pl) | 2013-03-15 | 2019-12-31 | Cancer Targeted Technology Llc | Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA |
| CA2915708C (en) | 2013-06-18 | 2018-02-06 | Aminomedix Inc. | Compositions and methods for the preparation of kidney protective agents comprising amifostine and amino acids |
| EP2862857A1 (en) | 2013-10-18 | 2015-04-22 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| JP2017530109A (ja) | 2014-09-08 | 2017-10-12 | モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド | 前立腺癌についてのｐｓｍａを標的とした放射性核種治療中の臓器の保護 |
-
2019
- 2019-05-08 WO PCT/EP2019/061882 patent/WO2020224780A1/en not_active Ceased
-
2020
- 2020-05-08 JP JP2021566582A patent/JP7436512B2/ja active Active
- 2020-05-08 US US17/608,921 patent/US20220304964A1/en active Pending
- 2020-05-08 EP EP22214592.2A patent/EP4218749A1/en not_active Withdrawn
- 2020-05-08 CA CA3135331A patent/CA3135331A1/en active Pending
- 2020-05-08 KR KR1020217036950A patent/KR102934560B1/ko active Active
- 2020-05-08 WO PCT/EP2020/062950 patent/WO2020225447A1/en not_active Ceased
- 2020-05-08 EP EP20725500.1A patent/EP3965751B1/en active Active
- 2020-05-08 CN CN202080033785.6A patent/CN114126654B/zh active Active
- 2020-05-08 ES ES20725500T patent/ES2938721T3/es active Active
- 2020-05-08 BR BR112021022200A patent/BR112021022200A2/pt not_active Application Discontinuation
- 2020-05-08 AU AU2020268836A patent/AU2020268836B2/en active Active
-
2021
- 2021-10-01 ZA ZA2021/07431A patent/ZA202107431B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022532187A5 (https=) | ||
| US20250057993A1 (en) | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancers | |
| JP7376481B2 (ja) | 鉛またはトリウム放射性核種に連結されたｐｓｍａ標的化化合物を含む錯体 | |
| Zamora et al. | Experimental radiotherapy of receptor‐positive human prostate adenocarcinoma with 188Re‐RC‐160, a directly‐radiolabeled somatostatin analogue | |
| CN112074526B (zh) | 作为治疗性放射性药物的177Lu-DOTA-HYNIC-iPSMA | |
| Bangard et al. | Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide | |
| JP2023547689A5 (https=) | ||
| JP2008531988A (ja) | 放射性標識ガリウム錯体、その合成法並びに悪性腫瘍におけるｅｇｆｒ発現のｐｅｔイメージングにおける使用 | |
| WO2024176147A1 (en) | Methods for treating breast cancer | |
| JP2001515494A (ja) | 診断及び治療のための放射能標識したソマトスタチン受容体リガンド | |
| US20230270893A1 (en) | Gallium-labeled gastrin analogue and use in a method of imaging cckb-receptor-positive tumors or cancers | |
| JP2025503096A (ja) | がんの処置および撮像のための複合体 | |
| Melo et al. | Tecnetium-99m as alternative to produce somatostatin-labeled derivatives: comparative biodistribution evaluation with 111in-dtpa-octreotide | |
| US12486294B2 (en) | Radioisotope labeled compound for imaging or treatment of prostate cancer | |
| RU2021133829A (ru) | Парааминогиппуровая кислота (паг), как вещество для защиты почек | |
| Ahn et al. | Radiometals for Positron Emission Tomography (PET) Imaging | |
| Ferro-Flores et al. | Preparation and evaluation of third generation technetium-99m radiopharmaceuticals | |
| HK40033441B (zh) | 作为治疗性放射性药物的177lu-dota-hynic-ipsma | |
| HK40120870A (en) | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancers | |
| HK40008701A (en) | Complex comprising a psma-targeting compound linked to a lead or thorium radionuclide | |
| Saranti | Study of radiolabeling of chemically modified bombesines | |
| EA040919B1 (ru) | 177Lu-DOTA-HYNIC-iPSMA В КАЧЕСТВЕ ТЕРАПЕВТИЧЕСКОГО РАДИОФАРМАЦЕВТИЧЕСКОГО СРЕДСТВА, НАЦЕЛЕННОГО НА ПРОСТАТИЧЕСКИЙ СПЕЦИФИЧЕСКИЙ МЕМБРАННЫЙ АНТИГЕН | |
| HK40008701B (en) | Complex comprising a psma-targeting compound linked to a lead or thorium radionuclide | |
| Hongsheng et al. | Preparation of {sup 188} Re-lanreotide as a potential tumor therapeutic agent | |
| HK40033441A (en) | 177lu-dota-hynic-ipsma as a therapeutic radiopharmaceutical |